Citations

Showing 10 of 108119 citations.

Recurrent nocardiosis in solid organ transplant recipients: An evaluation of secondary prophylaxis
Yetmar, Zachary A. , Wilson, John , Beam, Elena , Yetmar, Zachary A , Beam, Elena

Mayo Clinic

Transplant Infectious Disease | November 1, 2021 | Volume: 23 | Issue: 6 | Pages: No page available

10.1111/tid.13753 | PMID 34724316 Get It

AbstractBackgroundImmunocompromised individuals are at risk for Nocardia infection, with a recurrence rate of approximately 5%. Solid organ transplant (SOT) recipients often receive secondary prophylaxis due to their requirement of lifelong immunosuppression. However, data supporting this practice is sparse. We sought to evaluate Nocardia recurrence in SOT recipients, specifically evaluating secondary prophylaxis.MethodsWe conducted a retrospective cohort study of SOT recipients diagnosed with nocardiosis from 2000 through 2020. We included adult SOT recipients who completed their course of Nocardia therapy and had at least 6 months of posttherapy follow‐up. The primary outcome was Nocardia recurrence, which included relapse and reinfection.ResultsOne hundred two patients met inclusion criteria. Sixty‐six (64.7%) were male and mean age was 58.6 ± 11.7 years. Most common SOT types were kidney (46.1%), heart (18.6%), kidney‐pancreas (11.8%), and lung (10.8%). Most common sites of infection were lung (85.3%), skin (17.6%), and brain (14.7%). Secondary prophylaxis was utilized in 53 (52.0%) patients. Trimethoprim‐sulfamethoxazole (TMP‐SMX) single‐strength daily was the most common prophylaxis agent and dose. Five patients (4.9%) experienced Nocardia recurrence, three of which were receiving secondary prophylaxis at time of recurrence. Two recurrences were with the same Nocardia species. Factors associated with recurrence were lung transplantation (p = .011), chronic lung disease (p = .032), and treatment ≤120 days (p = .006). Time from treatment completion to recurrence ranged from 107 to 875 days.ConclusionsNocardia recurrence in SOT recipients is an uncommon event. TMP‐SMX secondary prophylaxis is incompletely protective and recurrence may be dependent upon other factors. Further study of secondary prophylaxis is warranted.
Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis
Karau, Melissa J., Schmidt-Malan, Suzannah M., Cunningham, Scott A., Mandrekar, Jayawant N., Pritt, Bobbi S. , Keepers, Tiffany R., Serio, Alisa W., Chitra, Surya, Patel, Robin , Patel, Robin , Pritt, Bobbi S , Karau, Melissa J., Schmidt-Malan, Suzannah M., Cunningham, Scott A., Mandrekar, Jayawant N., Keepers, Tiffany R., Serio, Alisa W., Chitra, Surya

Mayo Clinic

Antimicrobial Agents and Chemotherapy | November 1, 2021 | Volume: 66 | Issue: 1 | Pages: No page available

10.1128/aac.01703-21 | PMID 34723626 Get It

Omadacycline, vancomycin, and rifampin, as well as rifampin combination therapies, were evaluated in an experimental rat model of methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. All treatment groups had less MRSA recovered than saline-treated animals.
Polycystic Liver Disease: Advances in Understanding and Treatment
Masyuk, Anatoliy I. , Masyuk, Tatyana V. , LaRusso, Nicholas F.

Mayo Clinic

Annual Review of Pathology: Mechanisms of Disease | November 1, 2021 | Volume: 17 | Issue: 1 | Pages: 251-269

10.1146/annurev-pathol-042320-121247 | PMID 34724412 Get It

Polycystic liver disease (PLD) is a group of genetic disorders characterized by progressive development of cholangiocyte-derived fluid-filled hepatic cysts. PLD is the most common manifestation of autosomal dominant and autosomal recessive polycystic kidney diseases and rarely occurs as autosomal dominant PLD. The mechanisms of PLD are a sequence of the primary (mutations in PLD-causative genes), secondary (initiation of cyst formation), and tertiary (progression of hepatic cystogenesis) interconnected molecular and cellular events in cholangiocytes. Nonsurgical, surgical, and limited pharmacological treatment options are currently available for clinical management of PLD. Substantial evidence suggests that pharmacological targeting of the signaling pathways and intracellular processes involved in the progression of hepatic cystogenesis is beneficial for PLD. Many of these targets have been evaluated in preclinical and clinical trials. In this review, we discuss the genetic, molecular, and cellular mechanisms of PLD and clinical and preclinical treatment strategies.
Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination
Ashrani, Aneel A. , Crusan, Daniel J. , Petterson, Tanya M. , Bailey, Kent R. , Heit, John A. , Petterson, Tanya

Mayo Clinic

JAMA Internal Medicine | November 1, 2021 | Volume: 182 | Issue: 1 | Pages: 80

10.1001/jamainternmed.2021.6352 | PMID 34724036 Get It

Atypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes
Ko, Nway Le Ko, Sriramoju, Anil, Khetarpal, Banveet Kaur, Srivathsan, Komandoor, Ko Ko, Nway Le, Ko, Nway Le Ko, Sriramoju, Anil, Khetarpal, Banveet Kaur, Srivathsan, Komandoor

Mayo Clinic

Current Opinion in Cardiology | November 1, 2021 | Volume: 37 | Issue: 1 | Pages: 36-45

10.1097/hco.0000000000000924 | PMID 34857715 Get It

Purpose of review Atrial flutter (AFL) is the second most prevalent arrhythmia after atrial fibrillation (AF). It is a macro-reentrant tachycardia that is either cavotricuspid isthmus dependent (typical) or independent (atypical). This review aims at highlighting mechanism, diagnosis and treatment of atypical AFL and the recent developments in electroanatomic mapping. Recent findings Incidence of left AFL is at an exponential rise presently with increase in AF ablation rates. The mechanism of left AFL is most often peri-mitral, roof-dependent or within pulmonary veins in preablated, in contrast to posterior or anterior wall low voltage areas in ablation naïve patients. Linear lesions, compared to pulmonary vein isolation alone, have higher incidence of atypical right or left AFL. Catheter ablation for atypical AFL is associated with lower rates of thromboembolic events, transfusions, and length of stay compared to typical AFL. Summary Advances in mapping have allowed rapid simultaneous acquisition of automatically annotated points in the atria and identification of details of macro-reentrant circuits, including zones of conduction block, scar, and slow conduction.
Three-Dimensional Tendon Scaffold Loaded with TGF-β1 Gene Silencing Plasmid Prevents Tendon Adhesion and Promotes Tendon Repair
Wu, Genbin, Sun, Binbin , Zhao, Chunfeng , Wang, Zhuoying , Teng, Songsong, Yang, Mengkai, Cui, Zhi , Zhu, Guoliang , Yu, Yinxian

Mayo Clinic

ACS Biomaterials Science & Engineering | November 1, 2021 | Volume: 7 | Issue: 12 | Pages: 5739-5748

10.1021/acsbiomaterials.1c00747 | PMID 34723484 Get It

Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions
Rizk, Nesrine , Moghnieh, Rima , Haddad, Nisrine , Rebeiz, Marie‐Claire , Zeenny, Rony M. , Orlando, Gabriella , Rizk, Nesrine A , Hindy, Joya-Rita , Kanj, Souha S.

Mayo Clinic

Antibiotics | November 1, 2021 | Volume: 10 | Issue: 11 | Pages: 1320

10.3390/antibiotics10111320 | PMID 34827257 Get It

The COVID-19 pandemic is expected to worsen the global problem of antimicrobial resistance (AMR). There is a heightened interest in understanding this effect and to develop antimicrobial stewardship (AMS) interventions accordingly to curb this threat. Our paper aims to evaluate the potential magnitude of COVID-19 on AMR and AMS with a focus on the countries of the Arab league, given the social, political, and economic environments. We also evaluate obstacles in applying the rational use of antibiotics, monitoring resistance trends in the midst of the pandemic, and evaluating the impact of the economic crisis in some countries. We aim to raise awareness about the potential effects of antibiotic overuse during the pandemic and to propose practical approaches to tackle this issue.
Surgery for aortic re-coarctation in children less than 10 years old. A single center experience in Siberia, Russia
Egunov, O.A. , Cetta, Frank , Sokolov, Alexander N. , Sviazov, Evgenii A. , Shipulin, Vladimir V., Egunov, Oleg A , Кривощеков, Е. В. , Sokolov, Alexander, Shipulin, Vladimir V.

Mayo Clinic

No container title available | November 1, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.163577917.71763497/v1 Get It

Background: Persistence or recurrence of stenosis is a complication of initial coarctation repair. This study aims to report short-term outcomes of surgical management of recurrent coarctation and initial repair analysis. Methods: We retrospectively reviewed our experience with 51 patients undergoing recoarctation surgical repair between 2008 and 2019 using antegrade cerebral perfusion technique. Results: Surgical correction included prosthetic patch aortoplasty in 23 (45%), resection with wide end-to-end anastomosis in 15 (29%) and a tube interposition graft in 13 (25%) patients. Median age at initial correction and reintervention were 12 month and 9 years. Median interval from primary repair to reintervention was 60 months. Initial repair analysis revealed 33% of patients had initial correction in the neonatal period, 72,5% of patients were done via a left thoracotomy approach and 63% of patients had end-to-end anastomosis at initial surgery. Conclusion: Our study demonstrates that surgical repair of recurrent coarctation of the aorta using antegrade cerebral perfusion technique can be performed safely and with excellent results.
Impact of dual-energy 50-keV virtual monoenergetic images on radiologist confidence in detection of key imaging findings of small hepatocellular carcinomas using multiphase liver CT
Voß, Benjamin, Khandelwal, Ashish , Wells, Michael , Venkatesh, Sudhakar K. , Lee, Yong S. , Johnson, Matthew P. , Fletcher, Joel G. , Voss, Benjamin A, Wells, Michael L, Inoue, Akitoshi , Fletcher, Joel G , Venkatesh, Sudhakar K

Mayo Clinic

Acta Radiologica | November 1, 2021 | Volume: 63 | Issue: 11 | Pages: 1443-1452

10.1177/02841851211052993 | PMID 34723681 Get It

Background Dual-energy virtual monoenergetic images can increase iodine signal, potentially increasing the conspicuity of hepatic masses. Purpose To determine if dual-energy 50-keV virtual monoenergetic images improve visualization of key imaging findings or diagnostic confidence for small (≤2 cm) hepatocellular carcinomas (HCC) at multiphase, contrast-enhanced liver computed tomography (CT). Material and Methods Patients with chronic liver disease underwent multiphase dual-energy CT imaging for HCC, with late arterial and delayed phase dual-energy 50-keV images reconstructed. Two non-reader subspecialized gastrointestinal (GI) radiologists established the reference standard, determining the location and diagnosis of all hepatic lesions using predetermined criteria. Three GI radiologists interpreted mixed kV CT images without or with dual-energy 50-keV images. Radiologists identified potential HCCs and rated their confidence (0–100 scales) in imaging findings of arterial enhancement, enhancing capsule, tumor washout, and LI-RADS 5 (2018) category. Results In total, 45 patients (14 women; mean age = 59.5 ± 10.9 years) with chronic liver disease were included. Of them, 19 patients had 25 HCCs ≤2 cm (mean size = 1.5 ± 0.4 cm). There were 17 LI-RADS 3 and 4 lesions and 19 benign lesions. Reader confidence in imaging findings of arterial enhancement, enhancing capsule, and non-peripheral washout significantly increased with dual-energy images ( P ≤ 0.022). Overall confidence in HCC diagnosis increased significantly with dual-energy 50-keV images (52.4 vs. 68.8; P = 0.001). Dual-energy images demonstrated a slight but significant decrease in overall image quality. Conclusion Radiologist confidence in key imaging features of small HCCs and confidence in imaging diagnosis increases with use of dual-energy 50-keV images at multiphase, contrast-enhanced liver CT.
The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19
Christison, Amy L. , McGravery, Jeremy, Tekin, Aysun , Bolliger, Dawn, Kumar, Vishakha K. , Bansal, Vikas , Dapul, Heda , Bhalala, Utpal , Gharpure, Varsha , Heneghan, Julia A. , Gupta, Neha , Montgomery, Vicki , Arteaga, Grace M. , Choudhry, Asad , Kovačević, Tanja , Polić, Branka , Markić, Joško , Camazine, Maraya , Mosier, Jarrod , Menon, Shina , Asghar, Muhammad Sohaib , Shlomovich, Mark , Almazyad, Mohammed , Asfina, Kazi Nur , Galet, Colette , Carev, Dominko , Wen, Andy , Karam, Oliver , Levy, Emily, Bansal, Vikas , Gharpure, Varsha P , Asghar, Muhammad S , Tekin, Aysun , Mosier, Jarrod M , Karam, Oliver , Tripathi, Sandeep , Levy, Emily R. , Chiotos, Kathleen , Gist, Katja M. , Bjornstad, Erica C. , Walkey, Allan J. , Kashyap, Rahul , Menon, Shina

Mayo Clinic

Hospital Pediatrics | November 1, 2021 | Volume: 11 | Issue: 11 | Pages: e297-e316

10.1542/hpeds.2021-006087 | PMID 34168067 Get It

OBJECTIVE To describe the impact of obesity on disease severity and outcomes of coronavirus disease 2019 (COVID-19) among hospitalized children. METHODS This retrospective cohort study from the Society of Critical Care Medicine Viral Respiratory Illness Universal Study registry included all children hospitalized with COVID-19 from March 2020 to January 2021. Obesity was defined by Centers for Disease Control and Prevention BMI or World Health Organization weight for length criteria. Critical illness definition was adapted from National Institutes of Health criteria of critical COVID. Multivariate mixed logistic and linear regression was performed to calculate the adjusted odds ratio of critical illness and the adjusted impact of obesity on hospital length of stay. RESULTS Data from 795 patients (96.4% United States) from 45 sites were analyzed, including 251 (31.5%) with obesity and 544 (68.5%) without. A higher proportion of patients with obesity were adolescents, of Hispanic ethnicity, and had other comorbidities. Those with obesity were also more likely to be diagnosed with multisystem inflammatory syndrome in children (35.7% vs 28.1%, P = .04) and had higher ICU admission rates (57% vs 44%, P < .01) with more critical illness (30.3% vs 18.3%, P < .01). Obesity had more impact on acute COVID-19 severity than on multisystem inflammatory syndrome in children presentation. The adjusted odds ratio for critical illness with obesity was 3.11 (95% confidence interval: 1.8–5.3). Patients with obesity had longer adjusted length of stay (exponentiated parameter estimate 1.3; 95% confidence interval: 1.1–1.5) compared with patients without obesity but did not have increased mortality risk due to COVID-19 (2.4% vs 1.5%, P = .38). CONCLUSION In a large, multicenter cohort, a high proportion of hospitalized children from COVID-19 had obesity as comorbidity. Furthermore, obesity had a significant independent association with critical illness.